primary sclerosing cholangitis clinical trials
Sep 02, 2022
Novel Insights of Primary Sclerosing Cholangitis Treatment Market
There are a few major unmet needs in the primary sclerosing cholangitis (PSC) treatment market, which include a lack of effective therapies, proven surveillance strategies, tools for early detection of malignancies, impact on quality of life (QoL), and surrogate endpoints in primary sclerosing cholangitis clinical ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
